RGEN News and Press, Repligen Corporation From 06/15/20

WALTHAM, Mass., June 15, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment of healthcare industry executive Carrie Eglinton Manner to its Board of Directors. Ms. Eglinton Manner brings to the director role over 23 years of leadership experience acro...

First, let's talk about the positives The health of the stock market is confirmed by the true function of what it was built for, creating capital for new companies. Just this week we have news that Quicken Loans, Doordash, and Palantir are making moves to go public. Aside from Palantir, wh...

This selling is not about Wuhan Fever Redux This is not the fearsome second wave. The disease did not disappear from the first time around, so the spike in Texas and elsewhere is just that the disease started there later, so this rise is part of the cycle. Let’s also make note of ...

Investment Thesis Repligen 1-year share price performance. Source: TradingView Repligen ( RGEN ) is one of the few companies within the Life Sciences industry that has not withdrawn its 2020 guidance as a result of coronavirus, and the company's share price recovered rapidly since hittin...

Have you ever found yourself saying a stock is too expensive because it's made a big move in a short period of time? Or that a stock is too cheap to ignore because its price has fallen sharply? Anchoring bias, or the tendency to fixate on a past price when considering a new investment idea, ca...

Many investors tend to stay away from stocks that are appreciating strongly over time, mostly because of fears of buying too late when the stock is already overvalued. Having some patience when looking for entry prices and being conscious about valuation is very important. However, blindly avo...

Image source: The Motley Fool. Repligen   (NASDAQ: RGEN) Q1 2020 Earnings Call May 06, 2020 , 8:30 a.m. ET Operator Continue reading

Based on the simple facts that  Repligen (NASDAQ: RGEN) generated 65% of full-year 2019 revenue from customers engaged in clinical trials and many clinical trials have been delayed due to the coronavirus pandemic, I told investors the business could face a temporary slowdown  this ...

Repligen Corporation (RGEN) Q1 2020 Earnings Conference Call May 6, 2020, 08:30 AM ET Company Participants Sondra Newman - Senior Director, IR Tony Hunt - CEO & President Jon Snodgres - CFO & Secretary Conference Call Participants Tycho Peterson - JPMorgan John Kr...

Repligen (NASDAQ: RGEN ): Q1 Non-GAAP EPS of $0.32; GAAP EPS of $0.18 beats by $0.07 . More news on: Repligen Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...